May 2012

Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma

Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma

Yahoo

Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says

Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says

Bloomberg

R&D
Sanofi

BioMarin to Raise Funds

BioMarin to Raise Funds

Yahoo/Zacks

Human Genome Sciences Takeover Defense Survives Court Test

Human Genome Sciences Takeover Defense Survives Court Test

Bloomberg

New Drug Could Be Game Changer For Sanofi

New Drug Could Be Game Changer For Sanofi

Seeking Alpha

No Good News for Waiting Chelsea Investors

No Good News for Waiting Chelsea Investors

Motley Fool

The Drug Works, but Is It Worth Proceeding?

The Drug Works, but Is It Worth Proceeding?

Motley Fool

Medivation Emerges With New Prostate Cancer Drug

Medivation Emerges With New Prostate Cancer Drug

Xconomy

Teva Begins Trading on the New York Stock Exchange

Teva Begins Trading on the New York Stock Exchange

Yahoo

Icahn nominates new directors to Forest Labs board

Icahn nominates new directors to Forest Labs board

Yahoo/AP